COVID-19 vaccine hesitancy in Ethiopia: a scoping review for equitable vaccine access

Introduction: COVID-19 vaccines are crucial for preventing severe illness from the virus. Despite their effectiveness; vaccine hesitancy, unequal access, and economic disparities hinder vaccination programs across Africa, posing significant challenges in Ethiopia.

Method: This scoping review followed the methodological guidelines outlined in the Joanna Briggs Institute Reviewer's and employed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses - Extension for Scoping Reviews (PRISMA-ScR) checklist and explanation to ensure transparency. To analyze the data, we developed tailored search strategies for key databases [HINARI, PubMed, Cochrane, African Journals Online (AJOL), and Science Direct] and gray literature sources. These strategies combined controlled vocabulary and relevant keywords. A descriptive thematic analysis was then employed to identify and categorize the various findings within the included studies. The results are presented in a narrative format, summarizing the key themes and providing a clear and comprehensive overview of the current evidence base.

Results and recommendations: A review of 34 Ethiopian studies revealed significant COVID-19 vaccine hesitancy, with rates exceeding 50% in over 40% of the studies. The lowest hesitancy was found in adults from Addis Ababa (19.1%), while the highest rates were seen among healthcare workers in Oromia (69.7%) and pregnant women in Southwest Ethiopia (68.8%). Factors contributing to vaccine hesitancy in Ethiopia include being female, having only primary education, residing in rural areas, younger age, limited knowledge about the vaccine, reduced trust in authorities, and misperceptions about the risk of the virus. To address this challenge effectively, policymakers should prioritize interventions that build public trust, enhance awareness of the vaccine's benefits, and counter misinformation.

Introduction

1 Background

The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a significant loss of human lives worldwide and posed an unparalleled global health threat (1). The virus is contagious, spreads easily through contact and droplets. Prevention methods like distancing, hygiene, masks, and vaccines are crucial for control (2). As of June 2024, there have been over 884 million COVID-19 cases globally, with over 7 million deaths (3) and a total of 13,595,583,125 vaccine doses have been administered globally (4). While new infections slowed in Africa, the WHO African region reported over 8 million cases and 200,000 deaths (5). In Ethiopia, between January 2020 and November 2023, there were over 500,000 confirmed cases and over 7,500 deaths (6).

COVID-19 vaccines have proven highly effective in preventing symptomatic illness, with studies showing up to 95% effectiveness (7). Ethiopia began vaccinations on March 13, 2021, but as of May 27, 2023, only 59 people per 100 had received at least one dose, falling short of the global average of 74% (8). Vaccine hesitancy, the reluctance to get vaccinated despite availability, complex issue with many contributing factors. These factors range from demographics and political views to concerns about safety, lack of awareness, cultural beliefs, and socioeconomic considerations (9, 10).

COVID-19 vaccine hesitancy is a major hurdle, particularly in sub-Saharan Africa, where rates range from 14% in Ethiopia to a high of 65% in Tanzania. Several factors contribute to this hesitancy, including a history of unequal treatment in global health research, complex social and cultural beliefs, inadequate community engagement, and a general distrust in authorities (10–12).

Additionally, political influences, religious views, and a low perceived risk of contracting COVID-19 further hinder vaccine uptake in the region (13). Ethiopia faces a significant challenge in COVID-19 vaccination due to vaccine hesitancy, ranging from 14% to 69% across geographic divides, and this hesitancy stems from a combination of factors, including young age, female gender, rural residence, and limited access to information (14). To combat COVID-19 vaccine hesitancy and promote equitable access in Ethiopia, a multi-pronged approach is crucial. This includes developing culturally relevant educational materials, engaging trusted voices like religious leaders and community members, and addressing vaccine safety concerns through clear communication (15). Moreover, targeted outreach to populations with higher levels of hesitancy is crucial. Meaningful community engagement involving scientific experts plays a key role in building trust and countering misinformation (16). Additionally, addressing underlying factors contributing to hesitancy is key. Socio demographic factors like age, gender, and location, along with personal beliefs and access to accurate information, all play a role (10, 17). Vaccine hesitancy is a major hurdle to achieving equitable access to COVID-19 vaccines in Ethiopia (18–20, 15, 21). Thus, this scoping review aimed to investigates factors contributing to hesitancy and potential mitigation strategies by understanding these barriers, researchers can design interventions that promote vaccine acceptance, particularly among vulnerable populations. Increased focus on Africa-based research and development, improved stakeholder communication, and ensuring universal trust in vaccines are all crucial aspects of a multifaceted approach to achieving vaccine equity in low- and middle-income countries.

2 Method

2.1 Databases and search strategy

This scoping review was carried out following Arksey and O'Malley's methodological Framework (22). The framework consists of five stages: “(1), formulating the research questions,(2), conducting a comprehensive literature search (3), selecting relevant studies (4), extracting and organizing data and (5), synthesizing and reporting the findings.” This review adhered to the Preferred Reporting Items for Systematic Review and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) checklist (Supplementary Table-S1) (23).

The literature was identified through searches of various online databases, including HINARI, PubMed, Cochrane, African Journal Online (AJOL), and gray literature sourced through Google,Google Scholar, and other internet search engines. Medical Subject Heading (Mesh), keywords, and free text search terms were used. The search was conducted using the following terms: COVID-19 ‖ OR Coronavirus‖ OR nCoV Infection‖ OR SARS-CoV-2‖ OR COVID19,‖ MeSH terms: COVID-19 AND Vaccine‖ OR Vaccination,‖ MeSH terms: COVID-19 Vaccines AND (patterns)) AND Hesitancy OR indecision OR reluctance OR skepticism OR uncertainty AND approaches OR strategy OR method AND (barriers)) OR (factors)) OR(disfavor)) OR (dislike)) AND (equitable)) OR (Fair)) AND (timely)) OR (up-to-date)) OR (disadvantaged)) OR (underprivileged)) OR (vulnerable groups)) AND (Ethiopia). The search strategy was adapted from prior scoping or systematic reviews that assessed acceptance, uptake, and obstacles to achieving equitable and timely administration of COVID-19 and other vaccines Google Scholar, and other internet search engines. Medical Subject Heading (Mesh), keywords, and free text search terms were used. The search was conducted using the following terms: COVID-19 ‖ OR Coronavirus‖ OR nCoV Infection‖ OR SARS-CoV-2‖ OR COVID19,‖ MeSH terms: COVID-19 AND Vaccine‖ OR Vaccination, MeSH terms: COVID-19 Vaccines AND (patterns)) AND Hesitancy OR indecision OR reluctance OR skepticism OR uncertainty AND approaches OR strategy OR method AND (barriers)) OR (factors)) OR(disfavor)) OR (dislike)) AND (equitable)) OR (Fair)) AND (timely)) OR (up-to-date)) OR (disadvantaged)) OR (underprivileged)) OR (vulnerable groups)) AND (Ethiopia). The search strategy was adapted from prior scoping or systematic reviews that assessed acceptance, uptake, and obstacles to achieving equitable and timely administration of COVID-19 and other vaccines (24, 25).

2.2 Eligibility criteria

This scoping review sought to identify effective strategies for overcoming COVID-19 vaccine hesitancy in Ethiopia. We focused on original research published between January 2020 and early December 2023, specifically including studies conducted within Ethiopia that addressed COVID-19 vaccines. Studies solely focused on the virus itself, those from outside Ethiopia, or those not primarily focused on vaccination were excluded. Additionally, studies with incomplete or non-empirical data were omitted. This rigorous selection process ensures our review reflects the changing landscape of vaccine hesitancy in Ethiopia, offering valuable insights into current disparities in vaccine acceptance.

2.3 Outcome of interest

This review focused on COVID-19 vaccine hesitancy in Ethiopia, exploring the factors that contribute to it and proposing strategies to reduce hesitancy.

2.4 Data extraction and processing

JBA and MB independently extracted data using standardized Microsoft Excel sheet to categorize themes, summarize manuscripts, and ensure accuracy through double-checking and consensus with the primary investigator (SAB) on any discrepancies. The extraction focused on three key areas: study description (authors, year, region), methodology (design, sample size), and results (26). This research examined five key areas related to COVID-19 vaccination in Ethiopia: (1) vaccine hesitancy levels, (2) factors contributing to hesitancy (3) advocacy approaches for vaccine equity, (4) vaccine acceptance rates, and (5) barriers and solutions for equitable and timely uptake. Thematic narratives were employed to synthesize the data (26).

2.5 Data synthesis and analysis

Researchers employed a descriptive thematic analysis to categorize findings across the studies. This approach helped map the diverse strategies used in Ethiopia to promote equitable access to COVID-19 vaccines, reduce vaccine hesitancy, and ensure timely and equitable vaccine uptake. Key themes were then presented narratively, providing a comprehensive overview of the current evidence. Due to the heterogeneity of studies, a narrative synthesis approach was used to collect, synthesize, and map the literature.

2.6 Quality appraisal of the selected literature

All authors independently evaluated the quality of the studies included in the review. The Joanna Briggs Institute (JBI) framework was employed for assessing study quality (27). To evaluate the quality of evidence on factors associated with COVID-19 vaccine hesitancy and mitigation strategies in Ethiopia, we developed a scoring system. This system categorized studies as low (<49%), medium (50%–79%), or high (80%–100%) quality. To ensure the robustness and trustworthiness of our results, we implemented inter-rater reliability checks, peer reviews, and regular debriefing sessions within the research team. These iterative quality assurance measures facilitated discussions on emerging themes, refined interpretations, and ultimately enhanced the credibility of our research.

2.7 Ethics and dissemination

Since the data were collected from publicly available materials, this study does not require ethics approval.

2.8 Patient and public involvement

As this study is a scoping review, patient and public involvement (PPI) was not integrated at any stage of the research process, including the design, data collection, synthesis, reporting, or dissemination of findings.

3 Result

A systematic search identified 1,924 studies on COVID-19 vaccine hesitancy and mitigation strategies in Ethiopia. After removing duplicates (n = 804), 1,120 articles underwent title and abstract screening. We excluded 1,031 irrelevant studies and another 55 during full-text review (non-peer-reviewed, editorials, protocols, not on hesitancy or Ethiopia, or unavailable full text). The final analysis included 34 relevant studies. See the PRISMA flow diagram (Figure. 1) for details.

Figure 1

Figure 1. Flow chart of study.

3.1 COVID-19 vaccine hesitancy and associated factors in Ethiopia

3.1.1 Characteristics of studies included in the review of COVID-19 hesitancy in Ethiopia

Our analysis of COVID-19 vaccine hesitancy in Ethiopia included 34 studies selected based on pre-defined criteria. The studies exhibited significant heterogeneity in terms of region, design, and participant demographics. The studies were conducted across different regions and administrative cities in Ethiopia, except for six studies conducted in more than one region (28–31). The other studies were conducted in a single region. These included ten studies in the Amhara region (32–38) eight in the Southern Nations Nationalities and People (11, 28)(SNNPR) (40, 41–45)region, five in the Oromia region (46–50) one in the Sidama region (51) and one in the southwestern region of Ethiopia (4). In terms of study design and participants, twenty-three institutional-based cross-sectional studies were conducted among healthcare workers (4, 30, 52–55) and patients (15, 38, 40, 56–58), university students and staff (16, 29, 44, 54, 59–61) pregnant women and lactating mothers (14, 35, 45, 59) and seven community-based cross-sectional studies were conducted among the general population (17, 30, 62–64) or the adult population (9, 38, 41). Four studies were conducted as an E-survey among the general population (47, 50) and healthcare workers (46, 53). The total number of study participants included in the review was 18,151, with individual study sample sizes ranging from 301 (14) participants to 1,361 (65). Based on the Joanna Briggs Institute quality assessment criteria, none of the studies presented a considerable risk of bias; therefore, all were included in the review (66).

3.2 COVID-19 vaccine hesitancy in Ethiopia

The studies included in the review reported a percentage of vaccine hesitancy ranging from 19.1% (67) to 69.7% (12) (Table 1). About 42% of the included studies reported vaccine hesitancy rates higher than 50%. The lowest hesitancy rate of 19.1% was reported among adults in Addis Ababa (67), and the highest hesitancy rate of 69.7% was reported among healthcare providers in Oromia regional state (14) and followed by pregnant women (68.8%) in south west Ethiopia (59) (Table-1).

Table 1

Table 1. Studies included in the scoping review of COVID-19 vaccine hesitancy in Ethiopia.

3.3 Factors associated with COVID-19 vaccine hesitancy in Ethiopia

The analysis of this review revealed the following socio-demographic factors positively linked to COVID-19 vaccines hesitancy in Ethiopia: gender (female) (14, 15, 29, 38, 42, 67) age between 18 and 29 years (14, 40) age greater than 49 years (41, 42) age less than 23 years (59), primary education level (4, 68) religion (being Muslim) (69), rural residence (14, 40) and region of residence in the Afar and Sidama regions (11). There was also a positive correlation between income level and hesitancy towards COVID-19 vaccination (42, 71) and (14, 42, 51, 72).

A lack of sufficient information regarding the vaccines short- and long-term safety (58, 70), an undefined duration of vaccine protection (71) and (59) unclear information from a public health authority (4, 14, 72), sourcing of information from social media (4, 40, 72), insufficient knowledge (48, 73) and poor attitudes toward COVID-19 vaccines (73, 74), a low (7, 14, 42, 68, 42) and poor adherence to COVID-19 prevention measures (73, 76) were the most frequently studied individual factors. Additionally, negative self-efficacy, a history of perceived and confirmed COVID-19 infection (24, 51, 58, 77) and family members who died from COVID-19 (42, 71, 42, 78, 79) were found to be important positive factors in vaccine hesitancy. The vaccine-specific determinants identified in the analysis included a lack of belief in COVID- 19 vaccine benefits (11, 42, 68, 42), lack of trust in science to produce safe and effective vaccines (11, 33, 73, 80), and concerns about vaccine safety and side effects, as well as doubts about vaccine efficacy (30, 55, 58, 60, 75). Furthermore, beliefs for using traditional medicine to prevent and cure COVID-19 have been found to be vaccine-specific factors (14, 21, 39, 81).

3.4 Strategies to reduce COVID-19 vaccines hesitancy in Ethiopia

This scoping review identified a variety of strategies used to reduce vaccine hesitancy and improve advocacy for equity of the vaccines in Ethiopia. Among these strategies, efforts to increase awareness about the efficacy and safety of the COVID-19 vaccines, in collaboration with various health authorities and stakeholders, to design an evidence-based strategy to reduce vaccine hesitancy, reduce concerns about vaccines side effects and vaccines effectiveness; improve trust in COVID-19 vaccines products, and change beliefs regarding acquired

being superior to vaccination, change negative concerns about the COVID-19 vaccines and change beliefs about how to treat COVID-19 with traditional remedies were the most widely shared approaches in multiple studies (14, 44, 58, 73). Additionally, improving belief in COVID-19 vaccine benefits, improving knowledge of COVID-19, educating people about the vaccine, disseminating accurate information, particularly among women, changing fear of vaccine side effects and informing healthcare administrators about the widespread prevalence of COVID-19 vaccine hesitancy in the countries were widely identified approaches by the majority of the studies (11, 14–16, 15, 38, 42, 51, 67, 75, 42, 82).

For general communities, strategies such as strengthening public education using mass media about the advantages of receiving COVID-19 vaccination, providing enough information about the COVID-19 vaccine, enabling adequate preventive practices, changing fear of vaccine side effects, changing doubts about vaccines effectiveness, improving attitudes toward the COVID-19 vaccine, and motivating users to recommend the vaccine to other people were identified in multiple studies (18, 30, 45, 54, 59, 70, 75) Similarly, for the adult population, improving people's awareness of the COVID-19 vaccine, enhancing eHealth and computer literacy, and promoting awareness of the reliability of vaccine information sources, specifically designed, culturally tailored health education materials, and high levels of engagement in the vaccination process from politicians, women community leaders (Hadha sike‖) and community figure women, religious leaders, and other community members were reported by majority of studies (11, 13, 60, 83, 84).

To reduce vaccine hesitancy and improve advocacy and equity for the vaccine among healthcare providers, improving knowledge and attitudes toward the COVID-19 vaccine and increasing trust in COVID-19 vaccine products and changing beliefs regarding acquired immunity being superior to vaccination, changing negative perceptions about the safety of COVID-19 vaccines, improving beliefs about COVID-19 vaccine benefits and providing clear information about the vaccines were reported by multiples of studies (11, 24, 29, 39, 85, 86).

(Supplementary Table S2).

4 Discussion

This review provides a mapping of important studies and results on COVID-19 vaccine hesitancy and predictors in Ethiopia. It also explores strategies to encourage more people to get vaccinated fairly and on-time. The quality assessment of the included studies revealed that 27 studies were rated as high quality, 7 as moderate quality, and none as poor quality based on the JBI Critical Appraisal Checklist for Analytical Cross-Sectional Studies. The majority of the research papers included were cross-sectional and examined a variety of population groups. The analysis is based on data from over 18,151 participants across all regions of Ethiopia. The magnitude of vaccine hesitancy ranged from 19.1% (12) in Addis Ababa to 69.7% to Oromia (4). Majority (58.8%) of the included studies reported vaccine hesitancy rates lower than 50%. The highest levels of vaccination hesitancy shown in several of the included studies contrasted with research conducted in other locations, such as Europe and the Americas (17, 69), China (87) Kuwait (77), and the United Kingdom (88). This may be a direct result of disparities in vaccine access, and awareness of vaccine information between countries and region in the country. Studies showed that, people in middle- or high-income groups are more likely to get vaccinated (89), and inadequate financial considerations as barriers to vaccination acceptance (90). Even while many African governments provide free vaccinations to their citizens, the reluctance of resource- constrained communities may indicate a misunderstanding about who bears the cost. Similarly, the financial burden on such communities is likely to extend beyond the vaccine itself, including transportation to vaccination centers that may not be nearby, childcare fees, and other hurdles.

This review found that women in Ethiopia were more hesitant to get vaccinated than men, leading to lower vaccination rates among women. This finding aligns with a broader review of vaccine hesitancy in Africa, which reported that men were generally more likely to be (69) accepting of the COVID-19 vaccine (75). This finding also aligns with a Canadian study on COVID-19 vaccines, where women were more hesitant than men (91). Another study found low COVID-19 vaccine acceptance among women with primary education and unemployed women (81). This aligns with a global study on immunization attitudes, which reported that unemployed women were more likely to have concerns about vaccine safety and effectiveness (85). One possible explanation for the lower vaccine acceptance among some women might be persistent misconception of COVID-19 vaccines can cause fertility problems or birth defect (92).

This misconception has caused many young women of childbearing age to hesitate about vaccination and not to consider being vaccinated. In fact, a systematic review of a sample of 703,004 pregnant women globally revealed a lower rate of vaccination among them than among the rest of the population (93).

Similarly, the results of this review showed that low education level was a factor associated with vaccine acceptance and marginally associated with high vaccine hesitancy. This finding is consistent with other studies conducted elsewhere (77, 94, 58, 95). Education plays a significant role; in a Canadian study, individuals with less than a high school education showed lower adjusted odds of wanting to vaccinate themselves against COVID-19 compared to their counterparts (96). Furthermore, Black Americans with lower educational attainment are more hesitant to accept a COVID-19 vaccine (97). A study conducted in Latin America and the Caribbean disclosed similar findings but added that lower education influences vaccine hesitancy due to the general distrust in vaccines and the robustness of conspiracy beliefs across individuals with lower education levels (98). People with lower education levels and places with higher poverty rates (99, 100), such as sub-Saharan Africa (SSA), Latin America and the Caribbean rural regions, are more likely to be skeptical of vaccines and hold conspiracy theories. In these places, health promotion initiatives lack proper coverage, increasing the danger of misinformation and hence raising resistance to immunization and community mitigation strategies. It is vital to reinforce and tailor communication techniques to these demographics.

Tailored communication improves relevance; trust, and behavioral response, ultimately enhancing public health outcomes, for example messages targeting women should consider gender roles, health literacy, and caregiving responsibilities. Community-based communication, peer networks, and maternal health platforms can be effective channels (101). Content should be accessible, empathetic, and culturally sensitive. For rural communities, leveraging trusted local leaders (e.g., religious or community figures), radio broadcasts, and mobile health units is recommended due to limited internet access and health infrastructure (102).

Visual aids and local language translations also enhance message comprehension.

Healthcare workers respond well to evidence-based, concise, and actionable information delivered via professional platforms (e.g., WhatsApp groups, clinical bulletins, or in-service training). Peer-to-peer knowledge sharing and continuous medical education can also reinforce trust and uptake (102). Additionally, this review indicated that individuals living in rural areas were more reluctant to be vaccinated. Vaccination intentions would be lower in rural areas because of the low burden of the pandemic. Similarly, these findings might be explained by the idea of a certain innate immunity, by low exposure to information, or by their poor living standards compared to other parts of the nation. This finding differs from a study in Senegal, where vaccine hesitancy and refusal were linked to living in large cities (103). Significant differences in the likelihood of immunization in more rural areas may indicate other considerations that must be addressed when planning for COVID-19 vaccination implementation.

According to recent research, indigenous dwellers and those who live in rural areas are less likely to take preventive measures like wearing masks, but are more comfortable engaging in activities that require more social interaction. Given our findings, these behaviors could have severe effects for less densely populated, conservative societies s that may be resistant to present and future preventive interventions (104).

The herd immunity threshold for the virus that causes COVID-19, SARs- CoV-2, is predicted to be 55% to 82% (103), and achieving it will necessitate coordinated efforts across the country and across all administrative areas. In preparation for their involvement in COVID-19 vaccine administration, pharmacists and other providers must consider the importance of personal and community beliefs in influencing medical recommendations and subsequent actions taken to prevent the spread of infectious diseases across all regions of the country.

Lack of sufficient information, misinformation and poor attitude regarding vaccine safety were some of the other factors associated with vaccine hesitancy. This was consistent with studies conducted in different regions of Africa (15, 93, 58, 105), Europe and America (106, 107). When it comes to the fear of adverse effects, the influence of disinformation, particularly on social media platforms, was noted in practically every research setting. Social media has a significant capacity to mediate the spread of disinformation in anti-vaccine efforts (108). Some studies (40, 72) identified social media and, to a lesser extent, traditional media as the primary sources of erroneous information dissemination. Interestingly, despite being medical students, 91% of the respondents in Kanyike and colleagues' study (108), reported getting knowledge about COVID-19 via social media rather than health specialists. Misinformation on social media exacerbated their vaccine hesitation, despite the fact that they perceived an elevated risk as a result of their engagement in COVID-19 health interventions. As these findings demonstrate, social media has enormous power in effectively disseminating information and influencing health-seeking behaviors. These influences must be central to national programs addressing vaccination reluctance. It would entail modifying the content of campaigns to appeal to individuals more strongly than the misinformation that they so readily accept. Educational strategies emphasizing vaccine safety and efficacy have been identified in the literature as an important need to overcome misinformation and enhance compliance rates (109). As Zewude and Zikarge (42) established, vaccine hesitancy can be driven by public reaction to specific vaccines. The underlying principles in these interventions should be customized to reflect the various concerns about certain vaccines. These teaching campaigns could have a greater impact if they were targeted at those individuals identified as being most anxious about vaccination. This highlights the importance of collaboration among public health organizations, healthcare professionals, and media platforms to ensure accurate information, and to deliver programs that enhance attitudes and health literacy empowering the target population to make informed decisions.

Low perceived risk of getting COVID-19, distrust in science and vaccine safety, and doubts about the vaccine's effectiveness were also among the most important factors identified by this review. People who believed vaccination wouldn't protect them or might even harm their health were more likely to be hesitant or refuse the vaccine. A number of studies indicate that worries about the safety and effectiveness of vaccines seem to play a significant role in vaccine intention (110–112). Studies emphasized the need for targeting mistrust of vaccine manufacturers and the belief that COVID-19 vaccinations will be used as targets to damage Africa (72, 73, 111, 113). Respondents were skeptical since the pharmaceutical companies were foreign and scientists from their home nations were not engaged in producing the vaccines. Further longitudinal investigations will be required to supplement the findings of this research, given the advanced stages of vaccination campaigns in many countries. In order to establish equitable widespread vaccination campaigns related to COVID-19. Therefore, good communication regarding safety and efficacy and more transparency about vaccine development and distribution, including financial aspects, should be the made a cornerstone of all other measures efforts to ensure equitable and widespread vaccination campaigns especially related to COVID-19. In addition cultural beliefs, particularly the reliance on traditional medicine, significantly influence vaccine hesitancy in Ethiopia. Traditional healers are often regarded as trusted health authorities, and many communities favor herbal and spiritual remedies over biomedical interventions, which can foster skepticism toward vaccines especially when introduced without culturally sensitive engagement (114). Mistrust in the formal health system and the perceived efficacy of traditional practices further contribute to low vaccine uptake (115). To address these challenges, policy makers' public health campaigns should collaborate with traditional healers and religious leaders to foster community trust, deliver culturally appropriate messaging, and create inclusive dialogue platforms. Utilizing local languages and storytelling can also enhance message comprehension in rural and low-literacy settings (114). Respecting cultural frameworks while promoting evidence-based practices is essential to improving vaccine acceptance and immunization coverage.

The strengths of this study include being the first to consolidate studies and key factors of COVID-19 vaccine hesitancy and its mitigation strategies in Ethiopia, aiding targeted intervention programs. The analysis provides insight into the most significant contributors to vaccine hesitancy in the country. This indicates a predominance of high-quality research in the evaluation of COVID-19 vaccine hesitancy in Ethiopia. Additionally, the strength of the study on COVID-19 vaccine acceptance in Ethiopia is the inclusion of many articles with large sample sizes, providing a comprehensive overview. However, a limitation is the lack of studies from some regions of the country such as Tigray, Afar and Somali. Additionally, there was potential selection bias due to the inclusion of only published articles but this is but this does not affect the generalizability of the study due to the high quality of the article and the adequate sample size.

5 Conclusion

This scoping review highlights key factors driving COVID-19 vaccine hesitancy in Ethiopia, including younger age, rural residence, low educational attainment, female gender, and individual concerns related to vaccine safety, side effects, and perceived risk. Religious and cultural beliefs further influence vaccination decisions, underscoring the need for context-specific strategies. To effectively address these challenges, policymakers should engage trusted community figures such as religious leaders and elders and implement culturally appropriate communication efforts. Recommended actions include launching targeted media campaigns via local radio and social media to dispel misinformation, training healthcare workers in risk communication and community engagement, and collaborating with grassroots organizations to deliver tailored messages to high-risk groups, particularly women, youth, and rural populations. These integrated efforts can enhance vaccine confidence and promote equitable access to immunization across the country.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Author contributions

SB: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Supervision, Validation, Writing – original draft, Writing – review & editing. JA: Conceptualization, Supervision, Methodology, Writing – review & editing, Formal analysis. MD: Data curation, Methodology, Conceptualization, Formal analysis, Validation, Writing – original draft. MA: Formal analysis, Validation, Supervision, Writing – review & editing. YL: Validation, Supervision, Writing – review & editing. SG: Supervision, Validation, Writing – review & editing. EA: Project administration, Validation, Writing – review & editing. DA: Conceptualization, Project administration, Supervision, Writing – review & editing, Validation. GM: Validation, Conceptualization, Writing – review & editing. CM: Writing – original draft, Validation, Conceptualization, Methodology. JA: Methodology, Conceptualization, Writing – review & editing, Supervision. CI: Conceptualization, Validation, Writing – review & editing. EZ: Validation, Writing – review & editing. CN: Validation, Data curation, Formal analysis, Methodology, Writing – review & editing, Conceptualization, Supervision, Writing – original draft. JEA: Supervision, Writing – review & editing, Data curation, Writing – original draft, Methodology, Conceptualization, Validation.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This research project under which this manuscript was written was funded by the International Development Research Centre (IDRC). The manuscript specifically did not receive any funding, while the overall project's funders had no role in determining the study's outcomes.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Correction Note

This article has been corrected with minor changes. These changes do not impact the scientific content of the article.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/frhs.2025.1609752/full#supplementary-material

Abbreviations

COVID-19, Coronavirus disease 2019;IDRC, International Development and Research Centre; JBI, Joanna Briggs Institute; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PRISMA-ScR, Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews; SARS-CoV-2, severe acute respiratory syndrome-related coronavirus 2; UNECA, United Nations Economic Commission for Africa; WHO, World Health Organization.

References

1. Shishido AA, Mathew M, Baddley JW. Overview of COVID-19-associated invasive fungal infection. Curr Fungal Infect Rep. (2022) 16(3):87–97. doi: 10.1007/s12281-022-00434-0

PubMed Abstract | Crossref Full Text | Google Scholar

2. Campagnano S, Angelini F, Fonsi GB, Novelli S, Drudi FM. Diagnostic imaging in COVID-19 pneumonia: a literature review. J Ultrasound. (2021) 24(4):383–95. doi: 10.1007/s40477-021-00559-x

PubMed Abstract | Crossref Full Text | Google Scholar

3. Ahmad FB, Cisewski JA, Anderson RN. Mortality in the United States — provisional data, 2023. MMWR Morb Mortal Wkly Rep. (2024) 73(31):677–81. doi: 10.15585/mmwr.mm7331a1

PubMed Abstract | Crossref Full Text | Google Scholar

4. Teferi G, Kefale B. Coronavirus vaccine acceptance in Ethiopia: systematic review and meta-analysis. Int J Africa Nurs Sci. (2023) 19(January 2022):100598. doi: 10.1016/j.ijans.2023.100598

Crossref Full Text | Google Scholar

5. Dong E, Ratcliff J, Goyea TD, Katz A, Lau R, Ng TK, et al. The Johns Hopkins University Center for Systems Science and Engineering COVID-19 Dashboard: data collection process, challenges faced, and lessons learned. Lancet Infect Dis. (2022) 22(12):e370–6. doi: 10.1016/S1473-3099(22)00434-0

PubMed Abstract | Crossref Full Text | Google Scholar

6. Schumacher AE, Kyu HH, Antony CM, Aravkin AY, Azhar GS, Bisignano C, et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of. Lancet. (2024) 403(10440):1989–2056. doi: 10.1016/S0140-6736(24)00476-8

PubMed Abstract | Crossref Full Text | Google Scholar

7. Tavilani A, Abbasi E, Kian Ara F, Darini A, Asefy Z. COVID-19 vaccines: current evidence and considerations. Metab Open. (2021) 12:100124. doi: 10.1016/j.metop.2021.100124

PubMed Abstract | Crossref Full Text | Google Scholar

8. WHO Coronavirus Disease (COVID-19) Dashboard. Available online at: www.Covid19.who.int

Google Scholar

9. Alhassan RK, Aberese-Ako M, Doegah PT, Immurana M, Dalaba MA, Manyeh AK, et al. COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey. Trop Med Health. (2021) 49(1). doi: 10.1186/s41182-021-00357-5

PubMed Abstract | Crossref Full Text | Google Scholar

10. Babatope T, Ilyenkova V, Marais D. COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria. Bull Natl Res Cent. (2023) 47(1). doi: 10.1186/s42269-023-01017-w

PubMed Abstract | Crossref Full Text | Google Scholar

11. Muluneh MD, Negash K, Tsegaye S, Abera Y, Tadesse D, Abebe S, et al. COVID-19 Knowledge, attitudes, and vaccine hesitancy in Ethiopia: a community-based cross-sectional study. Vaccines (Basel). (2023) 11(4):774. doi: 10.3390/vaccines11040774

PubMed Abstract | Crossref Full Text | Google Scholar

12. Osuagwu UL, Mashige KP, Ovenseri-Ogbomo G, Envuladu EA, Abu EK, Miner CA, et al. The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-saharan Africa. BMC Public Health. (2023) 23(1):1–16. doi: 10.1186/s12889-022-14972-2

PubMed Abstract | Crossref Full Text | Google Scholar

13. Ekezie W, Igein B, Varughese J, Butt A, Ukoha-Kalu BO, Ikhile I, et al. Vaccination communication strategies and uptake in Africa: a systematic review. Vaccines (Basel). (2024) 12(12):1–31. doi: 10.3390/vaccines12121333

Crossref Full Text | Google Scholar

14. Yehualashet DE, Seboka BT, Tesfa GA, Mamo TT, Yawo MN, Hailegebreal S. Prevalence and determinants of COVID-19 vaccine hesitancy among the Ethiopian population: a systematic review. Risk Manag Healthc Policy. (2022) 15:1433–45. doi: 10.2147/RMHP.S368057

PubMed Abstract | Crossref Full Text | Google Scholar

15. Erega BB, Ferede WY, Sisay FA, Tiruneh GA, Ayalew AB, shigign ME, et al. COVID-19 vaccine hesitancy in Ethiopia in 2021: a multicenter cross-sectional study. IJID Reg. (2023) 6(August 2022):120–4. doi: 10.1016/j.ijregi.2022.11.006

PubMed Abstract | Crossref Full Text | Google Scholar

16. Tadesse TA, Antheneh A, Teklu A, Teshome A, Alemayehu B, Belayneh A, et al. COVID-19 Vaccine hesitancy and its reasons in Addis Ababa, Ethiopia: a cross-sectional study. Ethiop J Health Sci. (2022) 32(6):1061–70. doi: 10.4314/ejhs.v32i6.2

PubMed Abstract | Crossref Full Text | Google Scholar

17. Kukreti S, Rifai A, Padmalatha S, Lin CY, Yu T, Ko WC, et al. Willingness to obtain COVID-19 vaccination in general population: a systematic review and meta-analysis. J Glob Health. (2022) 12:05006. doi: 10.7189/jogh.12.05006

Crossref Full Text | Google Scholar

18. Wollburg P, Markhof Y, Kanyanda S, Zezza A. Assessing COVID-19 vaccine hesitancy and barriers to uptake in sub-saharan Africa. Commun Med. (2023) 3(1):1–11. doi: 10.1038/s43856-023-00330-9

PubMed Abstract | Crossref Full Text | Google Scholar

19. Hu B, Yang W, Bouanchaud P, Chongo Y, Wheeler J, Chicumbe S, et al. Determinants of COVID-19 vaccine acceptance in Mozambique: the role of institutional trust. Vaccine. (2023) 41(17):2846–52. doi: 10.1016/j.vaccine.2023.03.053

PubMed Abstract | Crossref Full Text | Google Scholar

20. Dubé E, Gagnon D, MacDonald NE, Eskola J, Liang X, Chaudhuri M, et al. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine. (2015) 33(34):4191–203. doi: 10.1016/j.vaccine.2015.04.041

PubMed Abstract | Crossref Full Text | Google Scholar

21. Orangi S, Pinchoff J, Mwanga D, Abuya T, Hamaluba M, Warimwe G, et al. Assessing the level and determinants of COVID-19 vaccine confidence in Kenya. Vaccines (Basel). (2021) 9(8):1–11. doi: 10.3390/vaccines9080936

Crossref Full Text | Google Scholar

22. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. (2005) 8(1):19–32. doi: 10.1080/1364557032000119616

Crossref Full Text | Google Scholar

23. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. (2018) 169(7):467–73. doi: 10.7326/M18-0850

PubMed Abstract | Crossref Full Text | Google Scholar

24. Anakpo G, Mishi S. Hesitancy of COVID-19 vaccines: rapid systematic review of the measurement, predictors, and preventive strategies. Hum Vaccines Immunother. (2022) 18(5). doi: 10.1080/21645515.2022.2074716

Crossref Full Text | Google Scholar

25. Robinson E, Jones A, Daly M. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company ‘ s public news and information. (2020).

Google Scholar

26. Lisy K, Porritt K. Narrative synthesis. Int J Evid Based Healthc. (2016) 14(4):201. doi: 10.1097/01.XEB.0000511348.97198.8c

Crossref Full Text | Google Scholar

27. Joanna Briggs Institute. Checklist for Systematic Reviews and Research Syntheses [Internet]. Adelaide, SA: Joanna Briggs Institute (2017). Available online at:. https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Systematic_Reviews2017_0.pdf

Google Scholar

28. Assefa A, Segenet Z. COVID-19 vaccine uptake and associated factors among health science university students in northeastern Ethiopia, a cross-sectional study. Hum Vaccin Immunother. (2023) 19:2208016. doi: 10.1080/21645515.2023.2208016

PubMed Abstract | Crossref Full Text | Google Scholar

29. Naidoo D, Meyer-Weitz A, Govender K. Factors influencing the intention and uptake of COVID-19 vaccines on the African continent: a scoping review. Vaccines (Basel). (2023) 11(4):1–33. doi: 10.3390/vaccines11040873

Crossref Full Text | Google Scholar

30. Taruvinga T, Chingono RS, Marambire E, Larsson L, Olaru ID, Sibanda S, et al. Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe: a mixed methods study. PLOS Glob Public Heal. (2023) 3(12):1–19. doi: 10.1371/journal.pgph.0002256

Crossref Full Text | Google Scholar

31. Endawkie A, Daba C, Asmare L, Desye B, Mawugatie TW, Melak D, et al. Trends of socioeconomic and geographic inequalities in COVID-19 vaccine uptake in Ethiopia: using the WHO health equity assessment toolkit. BMC Health Serv Res. (2024) 24(1). doi: 10.1186/s12913-024-12082-w

Crossref Full Text | Google Scholar

32. Tsegaw B, Kasahun F, Lemma T. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company ‘ s public news and information. (2020).

Google Scholar

33. Kalayou MH, Awol SM. Myth and misinformation on COVID-19 vaccine: the possible impact on vaccination refusal among people of Northeast Ethiopia: a community-based research. Risk Manag Healthc Policy. (2022) 15(September):1859–68. doi: 10.2147/RMHP.S366730

PubMed Abstract | Crossref Full Text | Google Scholar

34. Handebo S, Wolde M, Shitu K, Kassie A. Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar Town, Northwest Ethiopia. PLoS One. (2021) 16(6 June):1–11. doi: 10.1371/journal.pone.0253499

Crossref Full Text | Google Scholar

35. Aynalem ZB, Bogale TW, Bantie GM, Ayalew AF, Tamir W, Feleke DG, et al. Factors associated with willingness to take COVID-19 vaccine among pregnant women at Gondar Town, Northwest Ethiopia: a multicenter institution-based cross-sectional study. PLoS One. (2022) 17(11):e0276763. doi: 10.1371/journal.pone.0276763

PubMed Abstract | Crossref Full Text | Google Scholar

36. Alle YF, Oumer KE. Attitude and associated factors of COVID-19 vaccine acceptance among health professionals in Debre Tabor comprehensive Specialized Hospital, North Central Ethiopia; 2021: cross-sectional study. VirusDisease. (2021) 32(2):272–8. doi: 10.1007/s13337-021-00708-0

PubMed Abstract | Crossref Full Text | Google Scholar

37. Adane M, Ademas A, Kloos H. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia. BMC Public Health. (2022) 22(1):1–14. doi: 10.1186/s12889-021-12362-8

PubMed Abstract | Crossref Full Text | Google Scholar

38. Mehari EA, Mekonen TG, Adugnaw MT, Abdela OA. Prevalence of COVID-19 vaccine hesitancy and its associated factors among chronic disease patients in a resource limited setting in Ethiopia: a cross-sectional study. Adv Public Heal. (2022) 2023(1):1776205. doi: 10.1155/2023/1776205

Crossref Full Text | Google Scholar

39. Shah J, Abeid A, Sharma K, Manji S, Nambafu J, Korom R, et al. Perceptions and knowledge towards COVID-19 vaccine hesitancy among a subpopulation of adults in Kenya: an English survey at six healthcare facilities. Vaccines (Basel). (2022) 10(5):1–15. doi: 10.3390/vaccines10050705

Crossref Full Text | Google Scholar

40. Kabamba Nzaji M, Kabamba Ngombe L, Ngoie Mwamba G, Banza Ndala DB, Mbidi Miema J, Luhata Lungoyo C, et al. Acceptability of vaccination against COVID-19 among healthcare workers in the democratic republic of the Congo. Pragmatic Obs Res. (2020) 11:103–9. doi: 10.2147/POR.S271096

PubMed Abstract | Crossref Full Text | Google Scholar

41. Abebe H, Shitu S, Mose A. Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinates of COVID-19 vaccine acceptance among adult population in Ethiopia. Infect Drug Resist. (2021) 14:2015–25. doi: 10.2147/IDR.S312116

PubMed Abstract | Crossref Full Text | Google Scholar

42. Zewude B, Habtegiorgis T. Willingness to take COVID-19 vaccine among people most at risk of exposure in southern Ethiopia. Pragmatic Obs Res. (2021) 12:37–47. doi: 10.2147/POR.S313991

PubMed Abstract | Crossref Full Text | Google Scholar

43. Angelo AT, Alemayehu DS, Dachew AM. Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021. PLoS One. (2021) 16(9 September):1–15. doi: 10.1371/journal.pone.0257109

Crossref Full Text | Google Scholar

44. Mesele M. COVID-19 vaccination acceptance and its associated factors in Sodo Town, Wolaita zone, southern Ethiopia: cross-sectional study. Infect Drug Resist. (2021) 14:2361–7. doi: 10.2147/IDR.S320771

PubMed Abstract | Crossref Full Text | Google Scholar

45. Mose A. Willingness to receive COVID-19 vaccine and its determinant factors among lactating mothers in Ethiopia: a cross-sectional study. Infect Drug Resist. (2021) 14:4249–59. doi: 10.2147/IDR.S336486

PubMed Abstract | Crossref Full Text | Google Scholar

46. Fox AM, Choi Y, Lin L. Substantial disparities in COVID-19 vaccine uptake and unmet immunization demand in low- and middle-income countries. Health Aff. (2023) 42(12):1697–705. doi: 10.1377/hlthaff.2023.00729

PubMed Abstract | Crossref Full Text | Google Scholar

47. Seboka BT, Yehualashet DE, Belay MM, Kabthymer RH, Ali H, Hailegebreal S, et al. Factors influencing COVID-19 vaccination demand and intent in resource-limited settings: based on health belief model. Risk Manag Healthc Policy. (2021) 14:2743–56. doi: 10.2147/RMHP.S315043

PubMed Abstract | Crossref Full Text | Google Scholar

48. Kunyenje CA, Chirwa GC, Mboma SM, Ng’ambi W, Mnjowe E, Nkhoma D, et al. COVID-19 vaccine inequity in African low-income countries. Front Public Heal. (2023) 11:1087662. doi: 10.3389/fpubh.2023.1087662

PubMed Abstract | Crossref Full Text | Google Scholar

49. Momentum U, Immunization R. Covid-19 Vaccination Integration Assessment.

Google Scholar

50. Sanny JA. Africans are Split on COVID-19 Vaccination; Don't Trust Government to Ensure Vaccine Safety (Pan-Africa Profile No. 553). Accra: Afrobarometer (2022). p. 1–27.

Google Scholar

51. Yohannes S, Alemayehu A, Woldesenbet YM, Tadele T, Dangiso D, Birhanu M, et al. COVID-19 vaccine hesitancy among adults in hawassa city administration, sidama region, Ethiopia: a community-based study. Front Public Heal. (2023) 11:1122418. doi: 10.3389/fpubh.2023.1122418

PubMed Abstract | Crossref Full Text | Google Scholar

52. Mehari EA, Mekonen TG, Adugnaw MT, Abdela OA. Prevalence of COVID-19 vaccine hesitancy and its associated factors among chronic disease patients in a resource limited setting in Ethiopia: a cross-sectional study. Adv Public Health. (2022) 2023(1):1776205. doi: 10.1155/2023/1776205

Crossref Full Text | Google Scholar

53. Tebabere M, Tesfanesh L, Mulualem S, Moges S, Abayneh S, Temesgen G, et al. COVID-19 vaccine acceptance among health care professionals in Ethiopia: a systematic review and meta-analysis. Hum Vaccin Immunother. (2023) 19:2188854. doi: 10.1080/21645515.2023.2188854

PubMed Abstract | Crossref Full Text | Google Scholar

54. Wiysonge CS, Alobwede SM, de Marie C Katoto P, Kidzeru EB, Lumngwena EN, Cooper S, et al. COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa. Expert Rev Vaccines. (2022) 21(4):549–59. doi: 10.1080/14760584.2022.2023355

PubMed Abstract | Crossref Full Text | Google Scholar

55. Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. (2021) 27(8):1385–94. doi: 10.1038/s41591-021-01454-y

PubMed Abstract | Crossref Full Text | Google Scholar

56. Hu D, Kong Y, Li W, Han Q, Zhang X, Zhu LX, et al. Frontline nurses’ burnout, anxiety, depression, and fear statuses and their associated factors during the COVID-19 outbreak in Wuhan, China: a large-scale cross-sectional study. EClinicalMedicine. (2020) 24. doi: 10.1016/j.eclinm.2020.100424

Crossref Full Text | Google Scholar

57. Vagni M, Giostra V, Maiorano T, Santaniello G, Pajardi D. Personal accomplishment and hardiness in reducing emergency stress and burnout among COVID-19 emergency workers. Sustain. (2020) 12(21):9071. doi: 10.3390/su12219071

Crossref Full Text | Google Scholar

58. Berihun G, Walle Z, Berhanu L, Teshome D. Acceptance of COVID-19 vaccine and determinant factors among patients with chronic disease visiting dessie comprehensive specialized hospital, northeastern Ethiopia. Patient Prefer Adherence. (2021) 15:1795–805. doi: 10.2147/PPA.S324564

PubMed Abstract | Crossref Full Text | Google Scholar

59. Sahile AT, Gizaw GD, Mgutshini T, Gebremariam ZM, Bekele GE. COVID-19 Vaccine acceptance level in Ethiopia: a systematic review and meta-analysis. Can J Infect Dis Med Microbiol. (2022) 2022. doi: 10.1155/2022/2313367

PubMed Abstract | Crossref Full Text | Google Scholar

60. Eguavoen A, Larson H, Chinye-Nwoko F, Ojeniyi T. Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria. J Public Health Africa. (2023) 14(5). doi: 10.4081/jphia.2023.2290

Crossref Full Text | Google Scholar

61. Jalili M, Niroomand M, Hadavand F, Zeinali K, Fotouhi A. Burnout among healthcare professionals during COVID-19 pandemic: a cross-sectional study. Int Arch Occup Environ Health. (2021). doi: 10.1007/s00420-021-01695-x

PubMed Abstract | Crossref Full Text | Google Scholar

62. Tariq S, Hamza M, Muazzam A, Ahmer A, Mumtaz MT, Ahmad S. COVID-19 a brief overview. Brill Res Artif Intell. (2022) 2(3):107–13. doi: 10.47709/brilliance.v2i3.1601

Crossref Full Text | Google Scholar

63. Dula J, Mulhanga A, Nhanombe A, Cumbi L, Júnior A, Gwatsvaira J, et al. COVID-19 vaccine acceptability and its determinants in Mozambique: an online survey. Vaccines (Basel). (2021) 9(8):1–10. doi: 10.3390/vaccines9080828

Crossref Full Text | Google Scholar

64. Masresha B, Ruiz MAS, Atuhebwe P, Mihigo R. The first year of COVID-19 vaccine roll-out in Africa: challenges and lessons learned. Pan Afr Med J. (2022) 41(Supp 2):1–10. doi: 10.11604/pamj.supp.2022.41.2.33686

Crossref Full Text | Google Scholar

65. Bokolo M, Mansouri A, Michaud S. Perceptions and hesitancy towards the COVID-19 vaccination campaign among three vulnerable populations in the Democratic Republic of the Congo: a qualitative study. Niger Med J. (2024) 65(1):40–55. doi: 10.60787/nmj-v65i1-450

PubMed Abstract | Crossref Full Text | Google Scholar

66. Dos Santos WM, Secoli SR, de Araújo Püschel VA. The joanna briggs institute approach for systematic reviews. Rev Lat Am Enfermagem. (2018) 26:e3074. doi: 10.1590/1518-8345.2885.3074

PubMed Abstract | Crossref Full Text | Google Scholar

67. Dereje N, Tesfaye A, Tamene B, Alemeshet D, Abe H, Tesfa N, et al. COVID-19 vaccine hesitancy in Addis Ababa, Ethiopia: a mixed-method study. BMJ Open. (2022) 12(5):e052432. doi: 10.1136/bmjopen-2021-052432

PubMed Abstract | Crossref Full Text | Google Scholar

68. Zewude B, Belachew A. Intention to receive the second round of COVID-19 vaccine among healthcare workers in eastern Ethiopia. Infect Drug Resist. (2021) 14(July):3071–82. doi: 10.2147/IDR.S326055

PubMed Abstract | Crossref Full Text | Google Scholar

69. Belsti Y, Gela YY, Dagnew YAB, Getnet M, Seid MA, Diress M, et al. Willingness of Ethiopian population to receive COVID-19 vaccine. J Multidiscip Healthc. (2021) 14:1233–43. doi: 10.2147/JMDH.S312637

PubMed Abstract | Crossref Full Text | Google Scholar

70. Asres F, Umeta B. COVID-19 vaccines: awareness, attitude and acceptance among undergraduate university students. J Pharm Policy Pract. (2022) 15(1):1–7. doi: 10.1186/s40545-021-00397-6

PubMed Abstract | Crossref Full Text | Google Scholar

71. Hassen HD, Welde M, Menebo MM. Understanding determinants of COVID-19 vaccine hesitancy; an emphasis on the role of religious affiliation and individual’s reliance on traditional remedy. BMC Public Health. (2022) 22(1):1–11. doi: 10.1186/s12889-022-13485-2

PubMed Abstract | Crossref Full Text | Google Scholar

72. Gonçalves BA, de Souza Amorim Matos CC, dos Santos Ferreira JV, Itagyba RF, Moço VR, Couto MT. COVID-19 vaccine hesitancy in Latin America and Africa: a scoping review. Cad Saude Publica. (2023) 39(8):e00041423. doi: 10.1590/0102-311xpt041423

PubMed Abstract | Crossref Full Text | Google Scholar

73. Liga AD, Jabir YN, Bacha RH. COVID-19 vaccine acceptance and adherence to non-pharmaceutical interventions among employees of public transportations company in Addis Ababa, Ethiopia. Hum Vaccines Immunother. (2023) 19(1):1–7. doi: 10.1080/21645515.2023.2184759

Crossref Full Text | Google Scholar

74. Bereda G. Explore the reasons for SARS-CoV-2 vaccine hesitancy among healthcare workers: a cross- sectional study. Ann Med Surg. (2023) 85(6):2443–50. doi: 10.1097/MS9.0000000000000628

Crossref Full Text | Google Scholar

75. Ackah BBB, Woo M, Stallwood L, Fazal ZA, Okpani A, Ukah UV, et al. COVID-19 vaccine hesitancy in Africa: a scoping review. Glob Heal Res Policy. (2022) 7(1):1–20. doi: 10.1186/s41256-022-00255-1

Crossref Full Text | Google Scholar

76. Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C, et al. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Heal. (2021) 9(2):e120–9. doi: 10.1016/S2214-109X(20)30452-6

PubMed Abstract | Crossref Full Text | Google Scholar

77. Alqudeimat Y, Alenezi D, Alhajri B, Alfouzan H, Almokhaizeem Z, Altamimi S, et al. Acceptance of a COVID-19 vaccine and its related determinants among the general adult population in Kuwait. Med Princ Pract. (2021) 30(3):262–71. doi: 10.1159/000514636

PubMed Abstract | Crossref Full Text | Google Scholar

78. Zewudie A, Regasa T, Kebede O, Abebe L, Feyissa D, Ejata F, et al. Healthcare professionals’ willingness and preparedness to work during COVID-19 in selected hospitals of southwest Ethiopia. Risk Manag Healthc Policy. (2021) 14:391–404. doi: 10.2147/RMHP.S289343

PubMed Abstract | Crossref Full Text | Google Scholar

79. Terefa DR, Shama AT, Feyisa BR, Desisa AE, Geta ET, Cheme MC, et al. COVID-19 vaccine uptake and associated factors among health professionals in Ethiopia. Infect Drug Resist. (2021) 14:5531. doi: 10.2147/IDR.S344647

PubMed Abstract | Crossref Full Text | Google Scholar

80. Getachew Asmare A, Gizachew AK, Amanuel YG, Natnael AG, Molalegn MG, Endeshaw CA, et al. Knowledge and attitude towards COVID-19 vaccine in Ethiopia: systematic review and meta-analysis. Hum Vaccin Immunother. (2023) 19:2179224. doi: 10.1080/21645515.2023.2179224

PubMed Abstract | Crossref Full Text | Google Scholar

81. Bhattacharya O, Siddiquea BN, Shetty A, Afroz A, Billah B. COVID-19 vaccine hesitancy among pregnant women: a systematic review and meta-analysis. BMJ Open. (2022) 12(8):1–6. doi: 10.1136/bmjopen-2022-061477

Crossref Full Text | Google Scholar

82. Abubakari SW, Workneh F, Asante KP, Hemler EC, Madzorera I, Wang D, et al. Determinants of COVID-19 vaccine readiness and hesitancy among adults in sub-saharan Africa. PLOS Glob Public Heal. (2023) 3(7):e0000713. doi: 10.1371/journal.pgph.0000713

PubMed Abstract | Crossref Full Text | Google Scholar

83. Lawal L, Aminu Bello M, Murwira T, Avoka C, Yusuf Ma’aruf S, Harrison Omonhinmin I, et al. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward. Hum Vaccines Immunother. (2022) 18(1):1–5. doi: 10.1080/21645515.2022.2034457

Crossref Full Text | Google Scholar

84. Nigus M, Zelalem M, Abraham K, Shiferaw A, Admassu M, Masresha B. Implementing nationwide measles supplemental immunization activities in Ethiopia in the context of COVID-19: process and lessons learnt. Pan Afr Med J. (2020) 37(Supp 1):36. doi: 10.11604/pamj.supp.2020.37.1.26614

PubMed Abstract | Crossref Full Text | Google Scholar

85. Descamps A, Launay O, Bonnet C, Blondel B. Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey. Hum Vaccines Immunother. (2020) 16(5):1093–100. doi: 10.1080/21645515.2019.1688035

PubMed Abstract | Crossref Full Text | Google Scholar

86. Boro E, Stoll B. Barriers to COVID-19 health products in low-and middle-income countries during the COVID-19 pandemic: a rapid systematic review and evidence synthesis. Front Public Heal. (2022) 10:928065. doi: 10.3389/fpubh.2022.928065

PubMed Abstract | Crossref Full Text | Google Scholar

87. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. (2007) 4(1):0173–89. doi: 10.1371/journal.pmed.0040020

Crossref Full Text | Google Scholar

88. Williams L, Gallant AJ, Rasmussen S, Brown Nicholls LA, Cogan N, Deakin K, et al. Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: outlining evidence-based and theoretically informed future intervention content. Br J Health Psychol. (2020) 25(4):1039–54. doi: 10.1111/bjhp.12468

PubMed Abstract | Crossref Full Text | Google Scholar

89. Ditekemena JD, Nkamba DM, Mutwadi A, Mavoko HM, Fodjo JNS, Luhata C, et al. COVID-19 vaccine acceptance in the democratic Republic of Congo: a cross-sectional survey. Vaccines (Basel). (2021) 9(2):1–11. doi: 10.3390/vaccines9020153

Crossref Full Text | Google Scholar

90. Mustapha M, Lawal BK, Sha’aban A, Jatau AI, Wada AS, Bala AA, et al. Factors associated with acceptance of COVID-19 vaccine among university health sciences students in northwest Nigeria. PLoS One. (2021) 16(11 November):1–15. doi: 10.1371/journal.pone.0260672

Crossref Full Text | Google Scholar

91. Cénat JM, Noorishad PG, Moshirian Farahi SMM, Darius WP, Mesbahi El Aouame A, Onesi O, et al. Prevalence and factors related to COVID-19 vaccine hesitancy and unwillingness in Canada: a systematic review and meta-analysis. J Med Virol. (2023) 95(1). doi: 10.1002/jmv.28156

Crossref Full Text | Google Scholar

92. Schaler L, Wingfield M. COVID-19 vaccine—can it affect fertility? Ir J Med Sci. (2022) 191(5):2185–7. doi: 10.1007/s11845-021-02807-9

PubMed Abstract | Crossref Full Text | Google Scholar

93. Galanis P, Vraka I, Siskou O, Konstantakopoulou O, Katsiroumpa A, Kaitelidou D. Uptake of COVID-19 vaccines among pregnant women: a systematic review and meta-analysis. Vaccines (Basel). (2022) 10(5):766. doi: 10.3390/vaccines10050766

PubMed Abstract | Crossref Full Text | Google Scholar

94. Bhattacharya O, Siddiquea BN, Shetty A, Afroz A, Billah B. COVID-19 vaccine hesitancy among pregnant women: a systematic review and meta-analysis. BMJ Open. (2022) 12(8):e061477. doi: 10.1136/bmjopen-2022-061477

PubMed Abstract | Crossref Full Text | Google Scholar

95. Patwary MM, Alam MA, Bardhan M, Disha AS, Haque MZ, Billah SM, et al. COVID-19 Vaccine acceptance among low- and lower-middle-income countries: a rapid systematic review and meta-analysis. Vaccines (Basel). (2022) 10(3):427. doi: 10.3390/vaccines10030427

PubMed Abstract | Crossref Full Text | Google Scholar

96. Ogilvie GS, Gordon S, Smith LW, Albert A, Racey CS, Booth A, et al. Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada. BMC Public Health. (2021) 21(1):1–14. doi: 10.1186/s12889-021-11098-9

PubMed Abstract | Crossref Full Text | Google Scholar

97. Gatwood J, McKnight M, Fiscus M, Hohmeier KC, Chisholm-Burns M. Factors influencing likelihood of COVID-19 vaccination: a survey of Tennessee adults. Am J Heal Pharm AJHP Off J Am Soc Heal Pharm. (2021) 78(10):879–89. doi: 10.1093/ajhp/zxab099

PubMed Abstract | Crossref Full Text | Google Scholar

98. Hernandez AV, Benites-zapata VA. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company ‘ s public news and information. (2020).

Google Scholar

99. Atun R, de Andrade LOM, Almeida G, Cotlear D, Dmytraczenko T, Frenz P, et al. Health-system reform and universal health coverage in Latin America. Lancet (London, England). (2015) 385(9974):1230–47. doi: 10.1016/S0140-6736(14)61646-9

PubMed Abstract | Crossref Full Text | Google Scholar

100. French J, Deshpande S, Evans W, Obregon R. Key guidelines in developing a pre-emptive COVID-19 vaccination uptake promotion strategy. Int J Environ Res Public Health. (2020) 17(16):1–14. doi: 10.3390/ijerph17165893

Crossref Full Text | Google Scholar

101. Sampson M, Xu W, Prabhu S. Tailoring perinatal health communication: centering the voices of mothers at risk for maternal mortality and morbidity. Int J Environ Res Public Health. (2023) 20(1):186. doi: 10.3390/ijerph20010186

Crossref Full Text | Google Scholar

102. Asfaw S, Morankar S, Abera M, Mamo A, Abebe L, Bergen N, et al. Talking health: trusted health messengers and effective ways of delivering health messages for rural mothers in southwest Ethiopia. Arch Public Heal. (2019) 77:8. doi: 10.1186/s13690-019-0334-4

PubMed Abstract | Crossref Full Text | Google Scholar

103. Ba MF, Faye A, Kane B, Diallo AI, Junot A, Gaye I, et al. Factors associated with COVID-19 vaccine hesitancy in Senegal: a mixed study. Hum Vaccin Immunother. (2022) 18(5):2060020. doi: 10.1080/21645515.2022.2060020

PubMed Abstract | Crossref Full Text | Google Scholar

104. Samore T, Fessler DMT, Sparks AM, Holbrook C, Aarøe L, Baeza CG, et al. Greater traditionalism predicts COVID-19 precautionary behaviors across 27 societies. Sci Rep. (2023) 13(1):1–13. doi: 10.1038/s41598-023-29655-0

PubMed Abstract | Crossref Full Text | Google Scholar

105. Dinga JN, Njoh AA, Gamua SD, Muki SE, Titanji VPK. Factors driving COVID-19 vaccine hesitancy in Cameroon and their implications for Africa: a comparison of two cross-sectional studies conducted 19 months apart in 2020 and 2022. Vaccines (Basel). (2022) 10(9):1–14. doi: 10.3390/vaccines10091401

Crossref Full Text | Google Scholar

106. Khubchandani J, Macias Y. COVID-19 vaccination hesitancy in hispanics and African-Americans: a review and recommendations for practice. Brain, Behav Immun Heal. (2021) 15(May):100277. doi: 10.1016/j.bbih.2021.100277

PubMed Abstract | Crossref Full Text | Google Scholar

107. Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar MS, Chughtai NU, et al. COVID-19 Vaccine hesitancy in the United States: a systematic review. Front Public Heal. (2021) 9:770985. doi: 10.3389/fpubh.2021.770985

PubMed Abstract | Crossref Full Text | Google Scholar

108. Assegu YB, Bidu KT, Mosa AA, Bekele EA. Covid 19 vaccination implementation among preparatory school students in Akaki Kality sub city, Addis Ababa, Ethiopia. WJBPHS. (2024) 18(1):257–70. doi: 10.30574/wjbphs.2024.18.1.0203

Crossref Full Text | Google Scholar

109. Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. (2020) 35(8):775–9. doi: 10.1007/s10654-020-00671-y

PubMed Abstract | Crossref Full Text | Google Scholar

110. Al-Jayyousi GF, Sherbash MAM, Ali LAM, El-Heneidy A, Alhussaini NWZ, Elhassan MEA, et al. Factors influencing public attitudes towards COVID-19 vaccination: a scoping review informed by the socio-ecological model. Vaccines (Basel). (2021) 9(6):1–27. doi: 10.3390/vaccines9060548

Crossref Full Text | Google Scholar

111. Alabdulla M, Reagu SM, Al-Khal A, Elzain M, Jones RM. COVID-19 vaccine hesitancy and attitudes in Qatar: a national cross-sectional survey of a migrant-majority population. Influenza Other Respi Viruses. (2021) 15(3):361–70. doi: 10.1111/irv.12847

PubMed Abstract | Crossref Full Text | Google Scholar

112. Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England. Vaccine. (2020) 38(49):7789–98. doi: 10.1016/j.vaccine.2020.10.027

PubMed Abstract | Crossref Full Text | Google Scholar

113. Agyekum MW, Afrifa-Anane GF, Kyei-Arthur F, Addo B. Acceptability of COVID-19 vaccination among health care workers in Ghana. Adv Public Heal. (2021) 2021(1):9998176. doi: 10.1155/2021/9998176

Crossref Full Text | Google Scholar

114. Kassaye K, Amberbir A, Getachew B, Mussema Y. A historical overview of traditional medicine practices and policy in Ethiopia. Ethiop J Heal Dev. (2007) 20(2). doi: 10.4314/ejhd.v20i2.10023

Crossref Full Text | Google Scholar

115. Stoop N, Hirvonen K, Maystadt JF. Institutional mistrust and child vaccination coverage in Africa. BMJ Glob Heal. (2021) 6(4):e004595. doi: 10.1136/bmjgh-2020-004595

Crossref Full Text | Google Scholar